Cargando…

GSK3β inhibition restores cortical gamma oscillation and cognitive behavior in a mouse model of NMDA receptor hypofunction relevant to schizophrenia

Cortical gamma oscillations are believed to be involved in mental processes which are disturbed in schizophrenia. For example, the magnitudes of sensory-evoked oscillations, as measured by auditory steady-state responses (ASSRs) at 40 Hz, are robustly diminished, whereas the baseline gamma power is...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakao, Kazuhito, Singh, Mahendra, Sapkota, Kiran, Hagler, Bailey C., Hunter, Robert N., Raman, Chander, Hablitz, John J., Nakazawa, Kazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784891/
https://www.ncbi.nlm.nih.gov/pubmed/32859995
http://dx.doi.org/10.1038/s41386-020-00819-0
_version_ 1783632366017708032
author Nakao, Kazuhito
Singh, Mahendra
Sapkota, Kiran
Hagler, Bailey C.
Hunter, Robert N.
Raman, Chander
Hablitz, John J.
Nakazawa, Kazu
author_facet Nakao, Kazuhito
Singh, Mahendra
Sapkota, Kiran
Hagler, Bailey C.
Hunter, Robert N.
Raman, Chander
Hablitz, John J.
Nakazawa, Kazu
author_sort Nakao, Kazuhito
collection PubMed
description Cortical gamma oscillations are believed to be involved in mental processes which are disturbed in schizophrenia. For example, the magnitudes of sensory-evoked oscillations, as measured by auditory steady-state responses (ASSRs) at 40 Hz, are robustly diminished, whereas the baseline gamma power is enhanced in schizophrenia. Such dual gamma oscillation abnormalities are also present in a mouse model of N-methyl-D-aspartate receptor hypofunction (Ppp1r2cre/Grin1 knockout mice). However, it is unclear whether the abnormal gamma oscillations are associated with dysfunction in schizophrenia. We found that glycogen synthase kinase-3 (GSK3) is overactivated in corticolimbic parvalbumin-positive GABAergic interneurons in Grin1 mutant mice. Here we addressed whether GSK3β inhibition reverses both abnormal gamma oscillations and behavioral deficits with high correlation by pharmacological and genetic approach. We demonstrated that the paralog selective-GSK3β inhibitor, but not GSK3α inhibitor, normalizes the diminished ASSRs, excessive baseline gamma power, and deficits in spatial working memory and prepulse inhibition (PPI) of acoustic startle in Grin1 mutant mice. Cell-type specific GSK3B knockdown, but not GSK3A knockdown, also reversed abnormal gamma oscillations and behavioral deficits. Moreover, GSK3B knockdown, but not GSK3A knockdown, reverses the mutants’ in vivo spike synchrony deficits. Finally, ex vivo patch-clamp recording from pairs of neighboring cortical pyramidal neurons showed a reduction of synchronous spontaneous inhibitory-postsynaptic-current events in mutants, which was reversed by GSK3β inhibition genetically and pharmacologically. Together, GSK3β inhibition in corticolimbic interneurons ameliorates the deficits in spatial working memory and PPI, presumably by restoration of synchronous GABA release, synchronous spike firing, and evoked-gamma power increase with lowered baseline power.
format Online
Article
Text
id pubmed-7784891
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-77848912021-01-14 GSK3β inhibition restores cortical gamma oscillation and cognitive behavior in a mouse model of NMDA receptor hypofunction relevant to schizophrenia Nakao, Kazuhito Singh, Mahendra Sapkota, Kiran Hagler, Bailey C. Hunter, Robert N. Raman, Chander Hablitz, John J. Nakazawa, Kazu Neuropsychopharmacology Article Cortical gamma oscillations are believed to be involved in mental processes which are disturbed in schizophrenia. For example, the magnitudes of sensory-evoked oscillations, as measured by auditory steady-state responses (ASSRs) at 40 Hz, are robustly diminished, whereas the baseline gamma power is enhanced in schizophrenia. Such dual gamma oscillation abnormalities are also present in a mouse model of N-methyl-D-aspartate receptor hypofunction (Ppp1r2cre/Grin1 knockout mice). However, it is unclear whether the abnormal gamma oscillations are associated with dysfunction in schizophrenia. We found that glycogen synthase kinase-3 (GSK3) is overactivated in corticolimbic parvalbumin-positive GABAergic interneurons in Grin1 mutant mice. Here we addressed whether GSK3β inhibition reverses both abnormal gamma oscillations and behavioral deficits with high correlation by pharmacological and genetic approach. We demonstrated that the paralog selective-GSK3β inhibitor, but not GSK3α inhibitor, normalizes the diminished ASSRs, excessive baseline gamma power, and deficits in spatial working memory and prepulse inhibition (PPI) of acoustic startle in Grin1 mutant mice. Cell-type specific GSK3B knockdown, but not GSK3A knockdown, also reversed abnormal gamma oscillations and behavioral deficits. Moreover, GSK3B knockdown, but not GSK3A knockdown, reverses the mutants’ in vivo spike synchrony deficits. Finally, ex vivo patch-clamp recording from pairs of neighboring cortical pyramidal neurons showed a reduction of synchronous spontaneous inhibitory-postsynaptic-current events in mutants, which was reversed by GSK3β inhibition genetically and pharmacologically. Together, GSK3β inhibition in corticolimbic interneurons ameliorates the deficits in spatial working memory and PPI, presumably by restoration of synchronous GABA release, synchronous spike firing, and evoked-gamma power increase with lowered baseline power. Springer International Publishing 2020-08-28 2020-12 /pmc/articles/PMC7784891/ /pubmed/32859995 http://dx.doi.org/10.1038/s41386-020-00819-0 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Nakao, Kazuhito
Singh, Mahendra
Sapkota, Kiran
Hagler, Bailey C.
Hunter, Robert N.
Raman, Chander
Hablitz, John J.
Nakazawa, Kazu
GSK3β inhibition restores cortical gamma oscillation and cognitive behavior in a mouse model of NMDA receptor hypofunction relevant to schizophrenia
title GSK3β inhibition restores cortical gamma oscillation and cognitive behavior in a mouse model of NMDA receptor hypofunction relevant to schizophrenia
title_full GSK3β inhibition restores cortical gamma oscillation and cognitive behavior in a mouse model of NMDA receptor hypofunction relevant to schizophrenia
title_fullStr GSK3β inhibition restores cortical gamma oscillation and cognitive behavior in a mouse model of NMDA receptor hypofunction relevant to schizophrenia
title_full_unstemmed GSK3β inhibition restores cortical gamma oscillation and cognitive behavior in a mouse model of NMDA receptor hypofunction relevant to schizophrenia
title_short GSK3β inhibition restores cortical gamma oscillation and cognitive behavior in a mouse model of NMDA receptor hypofunction relevant to schizophrenia
title_sort gsk3β inhibition restores cortical gamma oscillation and cognitive behavior in a mouse model of nmda receptor hypofunction relevant to schizophrenia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784891/
https://www.ncbi.nlm.nih.gov/pubmed/32859995
http://dx.doi.org/10.1038/s41386-020-00819-0
work_keys_str_mv AT nakaokazuhito gsk3binhibitionrestorescorticalgammaoscillationandcognitivebehaviorinamousemodelofnmdareceptorhypofunctionrelevanttoschizophrenia
AT singhmahendra gsk3binhibitionrestorescorticalgammaoscillationandcognitivebehaviorinamousemodelofnmdareceptorhypofunctionrelevanttoschizophrenia
AT sapkotakiran gsk3binhibitionrestorescorticalgammaoscillationandcognitivebehaviorinamousemodelofnmdareceptorhypofunctionrelevanttoschizophrenia
AT haglerbaileyc gsk3binhibitionrestorescorticalgammaoscillationandcognitivebehaviorinamousemodelofnmdareceptorhypofunctionrelevanttoschizophrenia
AT hunterrobertn gsk3binhibitionrestorescorticalgammaoscillationandcognitivebehaviorinamousemodelofnmdareceptorhypofunctionrelevanttoschizophrenia
AT ramanchander gsk3binhibitionrestorescorticalgammaoscillationandcognitivebehaviorinamousemodelofnmdareceptorhypofunctionrelevanttoschizophrenia
AT hablitzjohnj gsk3binhibitionrestorescorticalgammaoscillationandcognitivebehaviorinamousemodelofnmdareceptorhypofunctionrelevanttoschizophrenia
AT nakazawakazu gsk3binhibitionrestorescorticalgammaoscillationandcognitivebehaviorinamousemodelofnmdareceptorhypofunctionrelevanttoschizophrenia